Ovarian Cancer Pathogenesis: A Model in Evolution

Por Karst, Alison M., Drapkin, Ronny
Publicado em 2010

The new face of ovarian cancer modeling: better prospects for detection and treatment

Por Karst, Alison M., Drapkin, Ronny
Publicado em 2011

Modeling high-grade serous ovarian carcinogenesis from the fallopian tube

Por Karst, Alison M., Levanon, Keren, Drapkin, Ronny
Publicado em 2011

Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas

Por Karst, Alison M., Levanon, Keren, Duraisamy, Sekhar, Liu, Joyce F., Hirsch, Michelle S., Hecht, Jonathan L., Drapkin, Ronny
Publicado em 2011

Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma

Por Novak, Marián, Lester, Jenny, Karst, Alison M., Parkash, Vinita, Hirsch, Michelle S., Crum, Christopher P., Karlan, Beth Y., Drapkin, Ronny
Publicado no Gynecol Oncol (2015)

Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells

Por Liu, Yugang, Qiang, Wenan, Xu, Xiaofei, Dong, Ruifen, Karst, Alison M., Liu, Zhaojian, Kong, Beihua, Drapkin, Ronny I., Wei, Jian-Jun
Publicado no Oncotarget (2015)

Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube derived high-grade serous ovarian cancers

Por Karst, Alison M., Jones, Paul M., Vena, Natalie, Ligon, Azra H., Liu, Joyce F., Hirsch, Michelle S., Etemadmoghadam, Dariush, Bowtell, David D. L., Drapkin, Ronny
Publicado no Cancer Res (2013)

Selective targeting of Cyclin E1 amplified high grade serous ovarian cancer by cyclin-dependent kinase 2 and AKT inhibition

Por Au-Yeung, George, Lang, Franziska, Azar, Walid J., Mitchell, Chris, Jarman, Kate E., Lackovic, Kurt, Aziz, Diar, Cullinane, Carleen, Pearson, Richard B, Mileshkin, Linda, Rischin, Danny, Karst, Alison M., Drapkin, Ronny, Etemadmoghadam, Dariush, Bowtell, David DL
Publicado no Clin Cancer Res (2016)

Transformation of the Fallopian Tube Secretory Epithelium Leads to High-grade Serous Ovarian Cancer in Brca;Tp53;Pten Models

Por Perets, Ruth, Wyant, Gregory A., Muto, Katherine W., Bijron, Jonathan G., Poole, Barish B., Chin, Kenneth T., Chen, Jin Yun H., Ohman, Anders W., Stepule, Corey D., Kwak, Soongu, Karst, Alison M., Hirsch, Michelle S., Setlur, Sunita R., Crum, Christopher P., Dinulescu, Daniela M., Drapkin, Ronny
Publicado em 2013

In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene

Por Dunn, Gavin P., Cheung, Hiu Wing, Agarwalla, Pankaj K., Thomas, Sapana, Zektser, Yulia, Karst, Alison M., Boehm, Jesse S., Weir, Barbara A., Berlin, Aaron M., Zou, Lihua, Getz, Gad, Liu, Joyce F., Hirsch, Michelle, Vazquez, Francisca, Root, David E., Beroukhim, Rameen, Drapkin, Ronny, Hahn, William C.
Publicado em 2014

Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer target ID4

Por Ren, Yin, Cheung, Hiu Wing, von Maltzhan, Geoffrey, Agrawal, Amit, Cowley, Glenn S., Weir, Barbara A., Boehm, Jesse S., Tamayo, Pablo, Karst, Alison M., Liu, Joyce F., Hirsch, Michelle S., Mesirov, Jill P., Drapkin, Ronny, Root, David E., Lo, Justin, Fogal, Valentina, Ruoslahti, Erkki, Hahn, William C., Bhatia, Sangeeta N.
Publicado em 2012